Literature DB >> 12376052

How should a birth cohort study be organised? Experience from the German MAS cohort study.

Renate Nickel1, Bodo Niggemann, Christoph Grüber, Michael Kulig, Ulrich Wahn, Susanne Lau.   

Abstract

Birth cohort studies offer the opportunity to study average risks, rates and occurrence times of disease longitudinally from birth. The effect of genetic and environmental factors and their interactions can be studied. Furthermore, quantity and duration of exposure to environmental agents can be evaluated prospectively. However, prospective birth cohort studies are expensive, labour intensive and take many years to complete. Loss of subjects over time as well as recall bias complicate the interpretation of observations. This paper summarises the potential pitfalls of such studies and discusses the experience of the German Multicentre Allergy Study (MAS), which began in 1990 in five German cities and included 1314 newborns for the study of the natural course of atopic diseases. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12376052     DOI: 10.1016/s1526-0542(02)00190-2

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  3 in total

1.  The Paris prospective birth cohort study: which design and who participates?

Authors:  B Clarisse; L Nikasinovic; R Poinsard; J Just; I Momas
Journal:  Eur J Epidemiol       Date:  2007-02-06       Impact factor: 8.082

2.  Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts.

Authors:  Zuelma A Contreras; Zhanghua Chen; Theano Roumeliotaki; Isabella Annesi-Maesano; Nour Baïz; Andrea von Berg; Anna Bergström; Sarah Crozier; Liesbeth Duijts; Sandra Ekström; Esben Eller; Maria P Fantini; Henrik Fomsgaard Kjaer; Francesco Forastiere; Beatrix Gerhard; Davide Gori; Margreet W Harskamp-van Ginkel; Joachim Heinrich; Carmen Iñiguez; Hazel Inskip; Thomas Keil; Manolis Kogevinas; Susanne Lau; Irina Lehmann; Dieter Maier; Evelien R van Meel; Monique Mommers; Mario Murcia; Daniela Porta; Henriëtte A Smit; Marie Standl; Nikos Stratakis; Jordi Sunyer; Carel Thijs; Maties Torrent; Tanja G M Vrijkotte; Alet H Wijga; Kiros Berhane; Frank Gilliland; Leda Chatzi
Journal:  Eur Respir J       Date:  2018-09-27       Impact factor: 16.671

Review 3.  Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015.

Authors:  J Bousquet; J M Anto; M Akdis; C Auffray; T Keil; I Momas; D S Postma; R Valenta; M Wickman; A Cambon-Thomsen; T Haahtela; B N Lambrecht; K C Lodrup Carlsen; G H Koppelman; J Sunyer; T Zuberbier; I Annesi-Maesano; A Arno; C Bindslev-Jensen; G De Carlo; F Forastiere; J Heinrich; M L Kowalski; D Maier; E Melén; S Palkonen; H A Smit; M Standl; J Wright; A Asarnoj; M Benet; N Ballardini; J Garcia-Aymerich; U Gehring; S Guerra; C Hohman; I Kull; C Lupinek; M Pinart; I Skrindo; M Westman; D Smagghe; C Akdis; R Albang; V Anastasova; N Anderson; C Bachert; S Ballereau; F Ballester; X Basagana; A Bedbrook; A Bergstrom; A von Berg; B Brunekreef; E Burte; K H Carlsen; L Chatzi; J M Coquet; M Curin; P Demoly; E Eller; M P Fantini; B Gerhard; H Hammad; L von Hertzen; V Hovland; B Jacquemin; J Just; T Keller; M Kerkhof; R Kiss; M Kogevinas; S Koletzko; S Lau; I Lehmann; N Lemonnier; R McEachan; M Mäkelä; J Mestres; E Minina; P Mowinckel; R Nadif; M Nawijn; S Oddie; J Pellet; I Pin; D Porta; F Rancière; A Rial-Sebbag; Y Saeys; M J Schuijs; V Siroux; C G Tischer; M Torrent; R Varraso; J De Vocht; K Wenger; S Wieser; C Xu
Journal:  Allergy       Date:  2016-08-23       Impact factor: 13.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.